Pharmacist Cardiovascular | Patient Safety | Treatment Guidelines Podcast 1 credit hour

Advancements in hypertension management are shifting the landscape of treatment, from new guideline recommendations to technological innovations. This course explores key highlights from the AHA’s recent scientific statements, including single-pill combination therapy and the clinical limitations of some blood pressure devices, alongside updates to the 2025 hypertension guidelines. You will gain a clear understanding of how these changes affect patient care, medication strategies, and pharmacist-driven interventions.

Available in Subscription

This course is included in the following subscription:

Pharmacist CE Subscription

Pharmacist CE Subscription

Renewed Annually
$99.00 / year

Learning Objectives

Upon successful completion of this course, pharmacists should be able to:
1. Identify recent guideline and practice updates that may influence the diagnosis, treatment, and monitoring of hypertension.
2. Discuss current and emerging tools and strategies that support safe, effective, and individualized hypertension management.

Faculty

Rachel Maynard, PharmD

GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

Disclosures:

Rachel Maynard has no relevant financial relationships with ineligible companies to disclose.

Tomasz Jurga, PharmD, BCPS, BCACP, BCCP, HF-Cert, CDCES, AACC

Clinical Pharmacist Practitioner

LTC Charles S. Kettles VA Medical Center

Disclosures:

Tomasz Jurga has disclosed that a grant from Merck supported Pharmacy Times Continuing Education activities, including speaking honoraria. All relevant financial relationships have been mitigated.

Course Details